Literature DB >> 11681417

Effects of overexpression of the SH2-containing inositol phosphatase SHIP on proliferation and apoptosis of erythroid AS-E2 cells.

A K Boer1, A L Drayer, E Vellenga.   

Abstract

Previous studies have demonstrated that SH2-containing inositol phosphatase (SHIP) is involved in the control of B cell, myeloid cell and macrophage activation and proliferation. The goal of the present study was to examine the role of SHIP during proliferation and apoptosis in cells of the erythroid lineage. Wild-type and catalytically inactive SHIP proteins were overexpressed in the erythropoietin (EPO)-dependent cell line AS-E2. Stable overexpression of catalytically inactive SHIP decreased proliferation and resulted in prolonged activation of the extracellular signal-regulated protein kinases ERK1/2 and protein kinase B (PKB), while wild-type SHIP did not affect EPO-mediated proliferation or phosphorylation of ERK and PKB. When AS-E2 cells were EPO deprived a significant increase in apoptosis was observed in clones overexpressing wild type. Mutational analysis showed that this increase in apoptosis was independent of the enzymatic activity of SHIP. The enhanced apoptosis due to overexpression of SHIP was associated with an increase in caspase-3 and -9 activity, without a distinct effect on caspase-8 activity or mitochondrial depolarization. Moreover, in cells overexpressing SHIP apoptosis could be reduced by a caspase-3 inhibitor. These data demonstrate that in the erythroid cell line AS-E2 overexpression of catalytically inactive SHIP reduced proliferation, while overexpression of wild-type SHIP had no effect. Furthermore, overexpression of SHIP enhanced apoptosis during growth factor deprivation by inducing specific caspase cascades, which are regulated independently of the 5-phosphatase activity of SHIP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11681417     DOI: 10.1038/sj.leu.2402261

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events.

Authors:  Jennifer M Green; Karen Leu; Angela Worth; Richard B Mortensen; David K Martinez; Peter J Schatz; Don M Wojchowski; Peter R Young
Journal:  Exp Hematol       Date:  2012-03-06       Impact factor: 3.084

2.  RNA-seq implicates deregulation of the immune system in the pathogenesis of diverticulitis.

Authors:  Kathleen M Schieffer; Christine S Choi; Scott Emrich; Leonard Harris; Sue Deiling; Dipti M Karamchandani; Anna Salzberg; Yuka I Kawasawa; Gregory S Yochum; Walter A Koltun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-06-15       Impact factor: 4.052

3.  A critical role for FcgammaRIIB in up-regulation of Fas ligand induced by a microbial polysaccharide.

Authors:  M Piccioni; C Monari; S Bevilacqua; S Perito; F Bistoni; T R Kozel; A Vecchiarelli
Journal:  Clin Exp Immunol       Date:  2011-05-23       Impact factor: 4.330

4.  Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma.

Authors:  Imran A Babar; Christopher J Cheng; Carmen J Booth; Xianping Liang; Joanne B Weidhaas; W Mark Saltzman; Frank J Slack
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-08       Impact factor: 11.205

5.  Identification of mitogen-activated protein kinase docking sites in enzymes that metabolize phosphatidylinositols and inositol phosphates.

Authors:  Kevin K Caldwell; Marcos Sosa; Colin T Buckley
Journal:  Cell Commun Signal       Date:  2006-01-30       Impact factor: 5.712

6.  Upregulation of SHIP2 participates in the development of breast cancer via promoting Wnt/β-catenin signaling.

Authors:  Juan Zhou; Manman Di; Hui Han
Journal:  Onco Targets Ther       Date:  2019-08-30       Impact factor: 4.147

Review 7.  Role of inositol poly-phosphatases and their targets in T cell biology.

Authors:  Neetu Srivastava; Raki Sudan; William Garrow Kerr
Journal:  Front Immunol       Date:  2013-09-23       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.